Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer

Journal of Biomedical Research

Volumn 27, Issue 3, 2013, Pages 179-192

  Wang, Meilin ^a,b   Chua, Haiyan ^a,b   Zhang, Zhengdong ^a,b   Wei, Qingyi ^c  

^a Nanjing Medical University   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

DNA repair; Genetic variation; Genome wide association study; Head and neck cancer; Molecular epidemiology

Indexed keywords

CARCINOGEN; LIG3 ENZYME; MISMATCH REPAIR PROTEIN PMS2; MUTAGENIC AGENT; NIBRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NUCLEIC ACID BINDING PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTEIN LIG4; PROTEIN MLH1; PROTEIN MSH6; PROTEIN OGG1; RAD51 PROTEIN; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING 5 PROTEIN; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN; XERODERMA PIGMENTOSUM GROUP F PROTEIN; XERODERMA PIGMENTOSUM GROUP G PROTEIN; XRCC1 PROTEIN; XRCC3 PROTEIN; XRCC4 PROTEIN;

ALCOHOL CONSUMPTION; ARTICLE; DNA POLYMORPHISM; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENVIRONMENTAL EXPOSURE; EXCISION REPAIR; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; HEAD AND NECK CANCER; HOMOLOGOUS RECOMBINATION; HUMAN; MISMATCH REPAIR; MOLECULAR EPIDEMIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; VIRUS INFECTION;

EID: 84891074615     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.27.20130034     Document Type: Article

References (152)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin 1999; 49: 33-64, 1
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29
3. Hashibe M, Boffetta P, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, et al. Evidence for an important role of alcoholand aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev 2006; 15: 696-703
4. Boffetta P, Hecht S, Gray N, Gupta P, Straif K. Smoke-less tobacco and cancer. Lancet Oncol 2008; 9: 667-75
5. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human pap-illomaviruspositive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008; 100: 261-9
6. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301
7. Negri E, Boffetta P, Berthiller J, Castellsague X, Curado MP, Dal Maso L, et al. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epi-demiology Consortium. Int J Cancer 2009; 124: 394-401
8. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291: 1284-9
9. Matullo G, Dunning AM, Guarrera S, Baynes C, Po-lidoro S, Garte S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006; 27: 997-1007
10. Lu AL, Li X, Gu Y, Wright PM, Chang DY. Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys 2001; 35: 141-70
11. Leibeling D, Laspe P, Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 225-38
12. Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer 2001; 1: 22-33
13. Khanna KK, Jackson SP. DNA doublestrand breaks: signaling, repair and the cancer connection. Nat Genet 2001; 27: 247-54
14. Mohrenweiser HW, Wilson DM, 3rd, Jones IM. Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003; 526: 93-125
15. Pegg AE, Byers TL. Repair of DNA containing O6-alkylguanine. FASEB J 1992; 6: 2302-10
16. Cheng L, Eicher SA, Guo Z, Hong WK, Spitz MR, Wei Q. Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998; 7: 465-8
17. Wang LE, Hu Z, Sturgis EM, Spitz MR, Strom SS, Amos CI, et al. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics. Clin Cancer Res 2010; 16: 764-74
18. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001; 409: 928-33
19. Ford BN, Ruttan CC, Kyle VL, Brackley ME, Glickman BW. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis 2000; 21: 1977-81
20. Izumi T, Hazra TK, Boldogh I, Tomkinson AE, Park MS, Ikeda S, et al. Requirement for human AP endonuclease 1 for repair of 3'-blocking damage at DNA single-strand breaks induced by reactive oxygen species. Carcinogen-esis 2000; 21: 1329-34
21. Fortini P, Pascucci B, Parlanti E, D'Errico M, Simonelli V, Dogliotti E. The base excision repair: mechanisms and its relevance for cancer susceptibility. Biochimie 2003; 85: 1053-71
22. Xi T, Jones IM, Mohrenweiser HW. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 2004; 83: 970-9
23. Lu J, Zhang S, Chen D, Wang H, Wu W, Wang X, et al. Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility. FASEB J 2009; 23: 3459-69
24. Lo YL, Jou YS, Hsiao CF, Chang GC, Tsai YH, Su WC, et al. A polymorphism in the APE1 gene promoter is associated with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2009; 18: 223-9
25. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD. Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 2001; 22: 917-22
26. Li C, Hu Z, Lu J, Liu Z, Wang LE, El-Naggar AK, et al. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer 2007; 110: 867-75
27. Gu D, Wang M, Zhang Z, Chen J. The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies. Mutagenesis 2009; 24: 507-12
28. Dantzer F, Schreiber V, Niedergang C, Trucco C, Flat-ter E, De La Rubia G, et al. Involvement of poly(ADP-ribose) polymerase in base excision repair. Biochimie 1999; 81: 69-75
29. Masutani M, Nakagama H, Sugimura T. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 2005; 62: 769-83
30. Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, et al. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64: 6344-8
31. Bieche I, de Murcia G, Lidereau R. Poly(ADP-ribose) polymerase gene expression status and genomic instability in human breast cancer. Clin Cancer Res 1996; 2: 1163-7
32. Ghabreau L, Roux JP, Frappart PO, Mathevet P, Patricot LM, Mokni M, et al. Poly(ADP-ribose) polymerase-1, a novel partner of progesterone receptors in endometrial cancer and its precursors. Int J Cancer 2004; 109: 317-21
33. Pabalan N, Francisco-Pabalan O, Jarjanazi H, Li H, Sung L, Ozcelik H. Racial and tissuespecific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis. Mol Biol Rep 2012; 39: 11061-72
34. Dianov GL, Souza-Pinto N, Nyaga SG, Thybo T, Ste-vnsner T, Bohr VA. Base excision repair in nuclear and mitochondrial DNA. Prog Nucleic Acid Res Mol Biol 2001; 68: 285-97
35. Dherin C, Radicella JP, Dizdaroglu M, Boiteux S. Ex-cision of oxidatively damaged DNA bases by the human alphahOgg1 protein and the polymorphic alphahOgg1(Ser326Cys) protein which is frequently found in human populations. Nucleic Acids Res 1999; 27: 4001-7
36. Park YJ, Choi EY, Choi JY, Park JG, You HJ, Chung MH. Genetic changes of hOGG1 and the activity of oh-8Gua glycosylase in colon cancer. Eur J Cancer 2001; 37: 340-6
37. Blons H, Radicella JP, Laccourreye O, Brasnu D, Beaune P, Boiteux S, et al. Frequent allelic loss at chromosome 3p distinct from genetic alterations of the 8-oxoguanine DNA glycosylase 1 gene in head and neck cancer. Mol Carcinog 1999; 26: 254-60
38. Weiss JM, Goode EL, Ladiges WC, Ulrich CM. Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol Carcinog 2005; 42: 127-41
39. Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, et al. Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomarkers Prev 2003; 12: 1100-4
40. Pawlowska E, Janik-Papis K, Rydzanicz M, Zuk K, Kaczmarczyk D, Olszewski J, et al. The Cys326 allele of the 8-oxoguanine DNA N-glycosylase 1 gene as a risk factor in smoking and drinking-associated larynx cancer. Tohoku J Exp Med 2009; 219: 269-75
41. Zhang Z, Shi Q, Wang LE, Sturgis EM, Spitz MR, El-Naggar AK, et al. No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Bi-omarkers Prev 2004; 13: 1081-3
42. Wikman H, Risch A, Klimek F, Schmezer P, Spiegelhal-der B, Dienemann H, et al. hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int J Cancer 2000; 88: 932-7
43. Sliwinski T, Przybylowska K, Markiewicz L, Rusin P, Pietruszewska W, Zelinska-Blizniewska H, et al. MU-TYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys-751Gln polymorphisms and head neck cancer suscep-tibility: a case control study. Mol Biol Rep 2011; 38: 1251-61
44. Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Laza-rus P. The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 2002; 23: 1229-34
45. Kowalski M, Przybylowska K, Rusin P, Olszewski J, Morawiec-Sztandera A, Bielecka-Kowalska A, et al. Ge-netic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res 2009; 28: 37
46. Kang SY, Lee KG, Lee W, Shim JY, Ji SI, Chung KW, et al. Polymorphisms in the DNA repair gene XRCC1 associated with basal cell carcinoma and squamous cell carcinoma of the skin in a Korean population. Cancer Sci 2007; 98: 716-20
47. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999; 20: 2125-9
48. Pratesi N, Mangoni M, Mancini I, Paiar F, Simi L, Livi L, et al. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. Radiother Oncol 2011; 99: 356-61
49. Csejtei A, Tibold A, Koltai K, Varga Z, Szanyi I, Gobel G, et al. Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Anticancer Res 2009; 29: 4169-73
50. Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, et al. Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2005; 14: 1747-53
51. Demokan S, Demir D, Suoglu Y, Kiyak E, Akar U, Da-lay N. Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol Oncol Res 2005; 11: 22-5
52. Tae K, Lee HS, Park BJ, Park CW, Kim KR, Cho HY, et al. Association of DNA repair gene XRCC1 polymor-phisms with head and neck cancer in Korean population. Int J Cancer 2004; 111: 805-8
53. Olshan AF, Watson MA, Weissler MC, Bell DA. XRCC1 polymorphisms and head and neck cancer. Cancer Lett 2002; 178: 181-6
54. Hu Z, Ma H, Chen F, Wei Q, Shen H. XRCC1 polymor-phisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1810-8
55. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcino-genesis 2000; 21: 965-71
56. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, Chang MJ, et al. Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smok-ers. Mutat Res 2002; 519: 93-101
57. Hu JJ, Smith TR, Miller MS, Lohman K, Case LD. Genetic regulation of ionizing radiation sensitivity and breast cancer risk. Environ Mol Mutagen 2002; 39: 208-15
58. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA. XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res 1999; 59: 2557-61
59. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, et al. XRCC1, XRCC3, XPD gene poly-morphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001; 22: 1437-45
60. Kiuru A, Lindholm C, Heilimo I, Ceppi M, Koivistoinen A, Ilus T, et al. Influence of DNA repair gene polymor-phisms on the yield of chromosomal aberrations. Environ Mol Mutagen 2005; 46: 198-205
61. Zhang K, Zhou B, Wang Y, Rao L, Zhang L. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: an update by meta-analysis of 53 individual studies. Gene 2012; 510: 93-101
62. Applebaum KM, McClean MD, Nelson HH, Marsit CJ, Christensen BC, Kelsey KT. Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer 2009; 124: 2690-6
63. Dianov GL, O'Neill P, Goodhead DT. Securing genome stability by orchestrating DNA repair: removal of radiation-induced clustered lesions in DNA. Bioessays 2001; 23: 745-9
64. Caldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH. An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase?. Mol Cell Biol 1994; 14: 68-76
65. Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, et al. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 353-8
66. Figueroa JD, Malats N, Real FX, Silverman D, Kogevi-nas M, Chanock S, et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007; 121: 233-42
67. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, et al. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 2009; 15: 740-6
68. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. As-sociation of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 2011; 73: 138-46
69. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2006; 27: 560-7
70. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, Loeffler JS, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 2010; 12: 37-48
71. Volker M, Mone MJ, Karmakar P, van Hoffen A, Schul W, Vermeulen W, et al. Sequential assembly of the nucleotide excision repair factors in vivo. Mol Cell 2001; 8: 213-24
72. Wu X, Zhao H, Wei Q, Amos CI, Zhang K, Guo Z, et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003; 24: 505-9
73. Park JY, Park SH, Choi JE, Lee SY, Jeon HS, Cha SI, et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 993-7
74. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S, et al. Gene-environment interaction in-volved in oral carcinogenesis: molecular epidemiologi-cal study for metabolic and DNA repair gene polymor-phisms. J Oral Pathol Med 2006; 35: 11-8
75. Bau DT, Tsai MH, Huang CY, Lee CC, Tseng HC, Lo YL, et al. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol 2007; 50: 294-300. 76
76. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. Laryngeal cancer risk associated with smok-ing and alcohol consumption is modified by genetic pol-ymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 2009; 125: 1431-9. 77
77. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkows-ka M, Korfanty J, Rzeszowska-Wolny J, et al. Asso-ciation between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet 2010; 51: 343-52. 78
78. Liu J, Zhang Z, Cao XL, Lei DP, Wang ZQ, Jin T, et al. XPA A23G polymorphism and susceptibility to cancer: a meta-analysis. Mol Biol Rep 2012; 39: 6791-9. 79
79. Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, et al. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev 2006; 15: 306-11. 80
80. Khan SG, Metter EJ, Tarone RE, Bohr VA, Grossman L, Hedayati M, et al. A new xeroderma pigmentosum group C poly(AT) insertion/deletion polymorphism. Carcino-genesis 2000; 21: 1821-5. 81
81. Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004; 25: 757-63. 82
82. Shen H, Sturgis EM, Khan SG, Qiao Y, Shahlavi T, Eicher SA, et al. An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res 2001; 61: 3321-5. 83
83. An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, et al. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 2007; 16: 1633-8. 84
84. Yang M, Kang MJ, Choi Y, Kim CS, Lee SM, Park CW, et al. Associations between XPC expression, genotype, and the risk of head and neck cancer. Environ Mol Mu-tagen 2005; 45: 374-9. 85
85. Wood RD. Nucleotide excision repair in mammalian cells. J Biol Chem 1997; 272: 23465-8. 86
86. Zhang L, Wang J, Xu L, Zhou J, Guan X, Jiang F, et al. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Mu-tagenesis 2012; 27: 67-76. 87
87. Li Y, Gu S, Wu Q, Fu X, Mao Y, Huang Y, et al. No association of ERCC1 C8092A and T19007C polymor-phisms to cancer risk: a meta-analysis. Eur J Hum Genet 2007; 15: 967-73
88. Yang M, Kim WH, Choi Y, Lee SH, Kim KR, Lee HS, et al. Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer. Eur J Cancer Prev 2006; 15: 269-73
89. Sturgis EM, Dahlstrom KR, Spitz MR, Wei Q. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2002; 128: 1084-8
90. Yang ZH, Dai Q, Kong XL, Yang WL, Zhang L. Association of ERCC1 polymorphisms and susceptibility to nasopharyngeal carcinoma. Mol Carcinog 2009; 48: 196-201
91. Cleaver JE. Common pathways for ultraviolet skin car-cinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J Dermatol Sci 2000; 23: 1-11
92. Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B, et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002; 23: 599-603
93. Benhamou S, Sarasin A. ERCC2/XPD gene polymor-phisms and cancer risk. Mutagenesis 2002; 17: 463-9
94. Majumder M, Sikdar N, Ghosh S, Roy B. Polymor-phisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 2007; 120: 2148-56
95. Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Be-suden M, et al. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 2008; 71: 887-97
96. Ji YB, Tae K, Lee YS, Lee SH, Kim KR, Park CW, et al. XPD Polymorphisms and Risk of Squamous Cell Car-cinoma of the Head and Neck in a Korean Sample. Clin Exp Otorhinolaryngol 2010; 3: 42-7
97. Gugatschka M, Dehchamani D, Wascher TC, Friedrich G, Renner W. DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck. Exp Mol Pathol 2011; 91: 331-4
98. Hu YY, Yuan H, Jiang GB, Chen N, Wen L, Leng WD, et al. Associations between XPD Asp312Asn polymor-phism and risk of head and neck cancer: a meta-analysis based on 7,122 subjects. PLoS One 2012; 7: e35220
99. Yuan H, Niu YM, Wang RX, Li HZ, Chen N. Associa-tion between XPD Lys751Gln polymorphism and risk of head and neck cancer: a meta-analysis. Genet Mol Res 2011; 10: 3356-64
100. Krupa R, Kasznicki J, Gajecka M, Rydzanicz M, Kiw-erska K, Kaczmarczyk D, et al. Polymorphisms of the DNA repair genes XRCC1 and ERCC4 are not associated with smoking and drinking-dependent larynx cancer in a Polish population. Exp Oncol 2011; 33: 55-6
101. Shi TY, He J, Qiu LX, Zhu ML, Wang MY, Zhou XY, et al. Association between XPF polymorphisms and cancer risk: a meta-analysis. PLoS One 2012; 7: e38606
102. Kiyohara C, Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007; 4: 59-71
103. Cui Y, Morgenstern H, Greenland S, Tashkin DP, Mao J, Cao W, et al. Polymorphism of Xeroderma Pigmentosum group G and the risk of lung cancer and squamous cell carcinomas of the oropharynx, larynx and esophagus. Int J Cancer 2006; 118: 714-20
104. Manuguerra M, Matullo G, Veglia F, Autrup H, Dunning AM, Garte S, et al. Multi-factor dimensionality reduction applied to a large prospective investigation on gene-gene and gene-environment interactions. Carcinogenesis 2007; 28: 414-22
105. Yuan H, Li H, Ma H, Niu Y, Wu Y, Zhang S, et al. Ge-netic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population. Exp Ther Med 2012; 3: 719-24
106. Ito E, Yanagisawa Y, Iwahashi Y, Suzuki Y, Nagasaki H, Akiyama Y, et al. A core promoter and a frequent single-nucleotide polymorphism of the mismatch repair gene hMLH1. Biochem Biophys Res Commun 1999; 256: 488-94
107. Arita M, Zhong X, Min Z, Hemmi H, Shimatake H. Multiple sites required for expression in 5'-flanking region of the hMLH1 gene. Gene 2003; 306: 57-65
108. Xu JL, Yin ZQ, Huang MD, Wang XF, Gao W, Liu LX, et al. MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studies. Asian Pac J Cancer Prev 2012; 13: 901-7
109. Pan XM, Yang WZ, Xu GH, Bai P, Qin HJ, Zhang LS, et al. The association between MLH1-93 G>A polymor-phism of DNA mismatch repair and cancer susceptibility: a meta-analysis. Mutagenesis 2011; 26: 667-73
110. Kouso H, Yoshino I, Miura N, Takenaka T, Ohba T, Yohena T, et al. Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance. J Surg Oncol 2008; 98: 377-83
111. Skarda J, Fridman E, Plevova P, Hajduch M, Radova L, Ofek E, et al. Prognostic value of hMLH1 and hMSH2 immunohistochemical expression in non-small cell lung cancer. A tissue microarray study. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006; 150: 255-9
112. Spaepen M, Vankeirsbilck B, Van Opstal S, Tejpar S, Van Cutsem E, Geboes K, et al. Germline mutations of the hMLH1 and hMSH2 mismatch repair genes in Belgian hereditary nonpolyposis colon cancer (HNPCC) patients. Fam Cancer 2006; 5: 179-89
113. Ravnik-Glavac M, Potocnik U, Glavac D. Incidence of germline hMLH1 and hMSH2 mutations (HNPCC patients) among newly diagnosed colorectal cancers in a Slovenian population. J Med Genet 2000; 37: 533-6
114. Ellison AR, Lofing J, Bitter GA. Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae. Hum Mol Genet 2001; 10: 1889-900
115. Drotschmann K, Clark AB, Kunkel TA. Mutator phenotypes of common polymorphisms and missense mutations in MSH2. Curr Biol 1999; 9: 907-10
116. Peltomaki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003; 21: 1174-9
117. Nicolaides NC, Papadopoulos N, Liu B, Wei YF, Carter KC, Ruben SM, et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371: 75-80
118. Mead LJ, Jenkins MA, Young J, Royce SG, Smith L, St John DJ, et al. Microsatellite instability markers for identifying earlyonset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Clin Cancer Res 2007; 13: 2865-9
119. Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A. DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2004; 112: 901-4
120. Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, Yang CH, et al. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 2008; 37: 271-7
121. Figueroa JD, Malats N, Rothman N, Real FX, Silverman D, Kogevinas M, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder can-cer risk. Carcinogenesis 2007; 28: 1788-93
122. Brenneman MA, Weiss AE, Nickoloff JA, Chen DJ. XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat Res 2000; 459: 89-97
123. Araujo FD, Pierce AJ, Stark JM, Jasin M. Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks. Oncogene 2002; 21: 4176-80
124. Yin QH, Liu C, Li L, Zu XY, Wang YJ. Association Be-tween the XRCC3 T241M Polymorphism and Head and Neck Cancer Susceptibility: a Meta-analysis of Case-control Studies. Asian Pac J Cancer Prev 2012; 13: 5201-5
125. Flores-Obando RE, Gollin SM, Ragin CC. Polymor-phisms in DNA damage response genes and head and neck cancer risk. Biomarkers 2010; 15: 379-99
126. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett 2005; 219: 125-35
127. Ricks-Santi LJ, Sucheston LE, Yang Y, Freudenheim JL, Isaacs CJ, Schwartz MD, et al. Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk. BMC Cancer 2011; 11: 278
128. Yu KD, Yang C, Fan L, Chen AX, Shao ZM. RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies. Breast Cancer Res Treat 2011; 126: 365-71
129. Sliwinski T, Walczak A, Przybylowska K, Rusin P, Pie-truszewska W, Zielinska-Blizniewska H, et al. Polymor-phisms of the XRCC3 C722T and the RAD51 G135C genes and the risk of head and neck cancer in a Polish population. Exp Mol Pathol 2010; 89: 358-66
130. Werbrouck J, De Ruyck K, Duprez F, Van Eijkeren M, Rietzschel E, Bekaert S, et al. Single-nucleotide poly-morphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res 2008; 656: 74-81
131. Gresner P, Gromadzinska J, Polanska K, Twardowska E, Jurewicz J, Wasowicz W. Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer. Gene 2012; 504: 166-74
132. Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q. 172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 2007; 28: 988-94
133. Tauchi H. Positional cloning and functional analysis of the gene responsible for Nijmegen breakage syndrome, NBS1. J Radiat Res 2000; 41: 9-17
134. Zheng J, Zhang C, Jiang L, You Y, Liu Y, Lu J, et al. Functional NBS1 polymorphism is associated with occurrence and advanced disease status of nasopharyngeal carcinoma. Mol Carcinog 2011; 50: 689-96
135. Tseng HC, Tsai MH, Chiu CF, Wang CH, Chang NW, Huang CY, et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer Res 2008; 28: 1687-91
136. Chiu CF, Tsai MH, Tseng HC, Wang CL, Wang CH, Wu CN, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 2008; 44: 898-902
137. Pfeiffer P, Goedecke W, Kuhfittig-Kulle S, Obe G. Pathways of DNA double-strand break repair and their impact on the prevention and formation of chromosomal aberrations. Cytogenet Genome Res 2004; 104: 7-13
138. Rothkamm K, Kruger I, Thompson LH, Lobrich M. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol 2003; 23: 5706-15
139. West SC. Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol 2003; 4: 435-45
140. Bau DT, Tseng HC, Wang CH, Chiu CF, Hua CH, Wu CN, et al. Oral cancer and genetic polymorphism of DNA double strand break gene Ku70 in Taiwan. Oral Oncol 2008; 44: 1047-51
141. Hsu CF, Tseng HC, Chiu CF, Liang SY, Tsai CW, Tsai MH, et al. Association between DNA double strand break gene Ku80 polymorphisms and oral cancer sus-ceptibility. Oral Oncol 2009; 45: 789-93
142. Yang H, Lippman SM, Huang M, Jack Lee J, Wang W, Spitz MR, et al. Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer 2008; 44: 1603-11
143. Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, DePinho RA, et al. The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A 2000; 97: 6630-3
144. Ding Z, Zhang J, Cheng Q, Shen J, Hu Y, Chen H. The LIG4 Ile658Val polymorphism does not affect the risk of cervical carcinoma. Pathol Res Pract 2010; 206: 556-9
145. Iwakuma T, Sakumi K, Nakatsuru Y, Kawate H, Igarashi H, Shiraishi A, et al. High incidence of nitrosamine-induced tumorigenesis in mice lacking DNA repair methyltransferase. Carcinogenesis 1997; 18: 1631-5
146. Zhang Z, Wang L, Wei S, Liu Z, Wang LE, Sturgis EM, et al. Polymorphisms of the DNA repair gene MGMT and risk and progression of head and neck cancer. DNA Repair (Amst) 2010; 9: 558-66
147. Kietthubthew S, Sriplung H, Au WW, Ishida T. Poly-morphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 2006; 209: 21-9
148. Hall J, Hashibe M, Boffetta P, Gaborieau V, Moullan N, Chabrier A, et al. The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract. Carcinogenesis 2007; 28: 665-71
149. Hardy J, Singleton A. Genomewide association studies and human disease. N Engl J Med 2009; 360: 1759-68
150. McKay JD, Truong T, Gaborieau V, Chabrier A, Chuang SC, Byrnes G, et al. A genome-wide association study of upper aerodigestive tract cancers conducted within the INHANCE consortium. PLoS Genet 2011; 7: e1001333
151. Yuan H, Ma H, Lu F, Yuan Z, Wang R, Jiang H, et al. Genetic variants at 4q23 and 12q24 are associated with head and neck cancer risk in China. Mol Carcinog 2012
152. Ghoussaini M, Song H, Koessler T, Al Olama AA, Kote-Jarai Z, Driver KE, et al. Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst 2008; 100: 962-6.